The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGuild Esports . Share News (GILD)

Share Price Information for Guild Esports . (GILD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.325
Bid: 0.30
Ask: 0.35
Change: 0.00 (0.00%)
Spread: 0.05 (16.667%)
Open: 0.325
High: 0.325
Low: 0.325
Prev. Close: 0.325
GILD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Guild Esports completes fundraise for working capital

Tue, 20th Jun 2023 14:09

Guild Esports PLC - London-based e-sports team organiser - Completes GBP622,200 fundraise via placing 103.7 million new shares at GBP0.006 per share. The net proceeds of the fundraise will be used for general working capital purposes, focused on driving growth.

Current stock price: 0.67 pence, down 4.0% on Tuesday

12-month change: down 59%

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Dec 2020 18:08

IN BRIEF: Guild Esports Launches Branded Digital Product Range

IN BRIEF: Guild Esports Launches Branded Digital Product Range

Read more
19 Nov 2020 17:35

Guild Esports Adds Fortnite Player Flikk To Its Esports Player Roster

Guild Esports Adds Fortnite Player Flikk To Its Esports Player Roster

Read more
21 Oct 2020 20:26

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

IN BRIEF: Guild Esports Signs Team To Compete In Valorant Game

Read more
19 Oct 2020 11:54

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Guild Esports Inks GBP3.6 Million Sponsorship Deal With Fintech Firm

Read more
21 Mar 2018 07:00

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.